What should get shareholders of Nuvilex excited about the company's future is the actual data the FDA used to quickly approve the ABRAXANE-gemcitabine combination for pancreatic cancer. $NVLX
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.